争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 1 条
2021
《每日快报》更正有关阿斯利康疫苗配方的虚假说法
公司回应
《每日快报》更正了一篇错误声称俄罗斯复制阿斯利康疫苗配方制造本国疫苗的文章。该报致歉，并刊载俄罗斯直接投资基金的回应。该说法涉及阿斯利康，但来源并未证实配方遭窃。
当事方说明的目的. 澄清事实。
品牌回应
道歉 — Daily Express
The British tabloid apologised for the publication of the false theft claim
澄清 — Daily Express
The Daily Express, a British tabloid, issued a correction to an 11 October article, which falsely claimed that "Russia [...] copied the formula of the AstraZeneca jab and used it to help make its own vaccine".
来源摘录
The Daily Express, a British tabloid, issued a correction to an 11 October article, which falsely claimed that "Russia [...] copied the formula of the AstraZeneca jab and used it to help make its own vaccine".
The British tabloid apologised for the publication of the false theft claim and sought to "set the record straight" by publishing the official response of the Russian Direct Investment Fund (RDIF), which funded the Sputnik V development.